CDC Financial’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
FLAM
PVM
NI
HWM
CDC Financial's HCAT Position: Q2 2026 in Review
CDC Financial increased its Health Catalyst (HCAT) stake by 12% in Q2 2026, buying an estimated $1.13M and bringing the position to 7,092,698 shares worth $14.1M. The position accounts for 5.91% of the portfolio, ranked #4.
CDC Financial first reported a position in HCAT in Q4 2025 and has held it in 3 quarters since. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.
- CDC Financial held 7,092,698 shares of Health Catalyst worth $14.1M as of Q2 2026.
- CDC Financial bought 785,644 Health Catalyst shares in Q2 2026, an estimated $1.13M.
- Health Catalyst made up 5.91% of CDC Financial's portfolio in Q2 2026, its #4 holding.
- CDC Financial first reported a position in Health Catalyst in Q4 2025 and has held it in 3 quarters since.
- 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.
Based on CDC Financial's 13F filing for Q2 2026, filed 14 Aug 2026.